CIK: 1360928 - Address: 1 Casper Street, Danbury, CT 06810
22 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret111100-11-5-9-2
S%wins55455545604050

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/4/19 07:51
12/2/19
ACORAcorda Therapeutics IncHealthBioPrdBiological Products, (No DiagSabella Lauren MNYOChief CoS-21.600-2-1113D
2/25/19 16:19
2/22/19
ACORAcorda Therapeutics IncHealthBioPrdBiological Products, (No DiagSabella Lauren MNYOChief CoS-1013.180-1-135D
12/21/18 17:17
6/28/18
ACORAcorda Therapeutics IncHealthBioPrdBiological Products, (No DiagSabella Lauren MNYOChief CoS.a-10527.840-4-347D
12/6/18 08:31
12/3/18
ACORAcorda Therapeutics IncHealthBioPrdBiological Products, (No DiagSabella Lauren MNYOChief CoS-10720.560-5-772D
7/2/18 07:52
6/28/18
ACORAcorda Therapeutics IncHealthBioPrdBiological Products, (No DiagSabella Lauren MNYOChief CoS-16327.840-6-525D
6/12/18 07:40
6/8/18
ACORAcorda Therapeutics IncHealthBioPrdBiological Products, (No DiagSabella Lauren MNYOChief CoM.d40216.5002411D
6/12/18 07:40
6/8/18
ACORAcorda Therapeutics IncHealthBioPrdBiological Products, (No DiagSabella Lauren MNYOChief CoS.d-85335.000-24-6911D
5/22/18 16:35
5/18/18
ACORAcorda Therapeutics IncHealthBioPrdBiological Products, (No DiagSabella Lauren MNYOChief CoS-17223.670-7-3911D
12/5/17 07:44
12/1/17
ACORAcorda Therapeutics IncHealthBioPrdBiological Products, (No DiagSabella Lauren MNYOChief CoS-3420.530-2-1015D
12/5/16 17:14
12/1/16
ACORAcorda Therapeutics IncHealthBioPrdBiological Products, (No DiagSabella Lauren MNYOChief CoS-5020.7412-2-1712D-45-45-32-161-2-2-221-330
12/23/15 09:16
12/22/15
ACORAcorda Therapeutics IncHealthBioPrdBiological Products, (No DiagSabella Lauren MNYOChief CoM.d15722.062079814D4472544151516600-7-40-39-57
12/23/15 09:16
12/22/15
ACORAcorda Therapeutics IncHealthBioPrdBiological Products, (No DiagSabella Lauren MNYOChief CoS.d-29942.0420-7-3314D4472544151516600-7-40-39-57
12/21/15 16:15
12/17/15
ACORAcorda Therapeutics IncHealthBioPrdBiological Products, (No DiagSabella Lauren MNYOChief CoM.d31422.061814999%14D3711532879622-11-36-41-57
12/21/15 16:15
12/17/15
ACORAcorda Therapeutics IncHealthBioPrdBiological Products, (No DiagSabella Lauren MNYOChief CoS.d-56940.0018-14-5014D3711532879622-11-36-41-57
12/3/15 16:44
12/1/15
ACORAcorda Therapeutics IncHealthBioPrdBiological Products, (No DiagSabella Lauren MNYOChief CoS-27038.0618-7-3314D11223151810-23215-2-21-44
12/3/14 21:20
12/1/14
ACORAcorda Therapeutics IncHealthBioPrdBiological Products, (No DiagSabella Lauren MNYOEVP-CommS-11535.5815-3-1815D4597151221-1-1510-4-181
12/9/13 16:02
12/5/13
ACORAcorda Therapeutics IncHealthBioPrdBiological Products, (No DiagSabella Lauren MNYOEVP-CommS-28031.8111-9-4112D3926-8-15-5-7-9-6-2-5-1019920
12/4/13 16:59
12/2/13
ACORAcorda Therapeutics IncHealthBioPrdBiological Products, (No DiagSabella Lauren MNYOEVP-CommS-22133.5212-7-2421D46383-6331-3-2-3-817914
11/25/13 17:55
11/22/13
ACORAcorda Therapeutics IncHealthBioPrdBiological Products, (No DiagSabella Lauren MNYOEVP-CommS-36933.7214-11-2828D59362-15623-1-4-165-64
12/5/12 16:23
12/4/12
ACORAcorda Therapeutics IncHealthBioPrdBiological Products, (No DiagSabella Lauren MNYOEVP-CommS-10724.586-4-1232D-5711863-1-2-1210213328
12/5/11 15:57
12/1/11
ACORAcorda Therapeutics IncHealthBioPrdBiological Products, (No DiagSabella Lauren MNYOEVP-CommS-10022.9112-4-1427D-6-15-27-73-352131014-112
12/3/10 16:00
12/1/10
ACORAcorda Therapeutics IncHealthBioPrdBiological Products, (No DiagSabella Lauren MNYOEVP-CommS-10426.5315-4-1621D626-25-182-6-1-21-12-1721-12

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact